TSM's 90% grip on advanced nodes and 100% utilization proves AI chip scarcity is structural—no viable challengers exist.

Instead of waiting for schools or policymakers to address the talent gap, Humtown Products took the initiative to create a ...

Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and technologies that improve patient outcomes. Editor’s Note: This is part three ...